Personally, I very much hope it can somehow stay as Australian technology (if that is the word). But the only way I could imagine this happening is if NEU 'farm out' trials to one or more BP for different conditions. Whether they would accept this or not I do not know. But you would think NEU would have to be in the box seat right now. Would be disappointing if these drugs are not trialed asap for Parkinsons / Autism +++++. I do agree with everyone that the team at NEU just seem fantastic, smart and caring. Would be amazed if Acadia are not trialing Fragile X shortly. Will soon find out soon-ish what is possible I guess.
Thanks for the post, Prismen.
All the best to all...
Share Price, page-8495
-
- There are more pages in this discussion • 2,460 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.22 |
Change
0.120(0.60%) |
Mkt cap ! $2.579B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.43 | $20.14 | $765.6K | 37.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 90 | $20.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.23 | 26 | 1 |
View Market Depth
| Last trade - 11.38am 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |